A cytopathologist is a physician who diagnoses diseases by examining individual cells rather than chunks of tissue. While a surgeon removes a lump and a radiologist images it, the cytopathologist is the specialist who looks at cells under a microscope and determines whether they’re normal, infected, or cancerous. They complete medical school, a pathology residency, and an additional year-long fellowship focused specifically on cell-level diagnosis.
Most people encounter a cytopathologist’s work without ever meeting one. Every Pap test result, for example, is interpreted by a cytopathologist or under their oversight. But their role extends well beyond cervical screening into nearly every organ system in the body.
What Cytopathologists Actually Do
The core job is interpreting cells collected from the body and making a diagnosis. Those cells can come from a swab (like a Pap test), from fluid drained from the chest or abdomen, or from a needle inserted directly into a suspicious mass. A major part of the work involves reading Pap tests, the screening tool used to detect precancerous and cancerous changes in cervical cells. But cytopathologists also diagnose thyroid nodules, lung masses, liver lesions, lymph node abnormalities, and soft tissue tumors.
They serve as consultants to virtually every other medical specialty. An endocrinologist who finds a thyroid nodule, a pulmonologist investigating a lung shadow, or a gastroenterologist sampling a pancreatic cyst all rely on a cytopathologist to tell them what they’re dealing with.
How Cell Diagnosis Differs From Tissue Diagnosis
Pathology broadly splits into two approaches. Surgical pathologists examine tissue samples, pieces of organ that preserve the architecture of how cells are arranged. Cytopathologists work with individual cells or small clusters, typically collected through less invasive methods like fine needle aspiration (FNA). Think of it as the difference between studying a brick wall versus studying individual bricks.
Each approach has trade-offs. Tissue biopsies preserve structure, making it easier to identify exactly what type of tumor is present. In one large study comparing both methods across more than 800 soft tissue and bone lesions, tissue biopsies correctly identified the specific tumor type in 90% of cases that yielded a diagnosis, compared to 88% for cell samples. Cell-based sampling, however, produced fewer complications, required no anesthesia, and gave faster results. FNA cytology had a sensitivity of 87% and specificity of 89% for distinguishing cancerous from noncancerous lesions. The insufficient-material rate was similar for both approaches, around 4 to 5%.
In practice, these methods complement each other. A cytopathologist might use FNA to quickly determine whether a mass is malignant, and if more detail is needed, a tissue biopsy follows.
Real-Time Guidance During Procedures
One of the more hands-on parts of the job is called Rapid On-Site Evaluation, or ROSE. During a needle biopsy, the cytopathologist stands in the procedure room, stains the sample on the spot, examines it under a microscope, and tells the radiologist or surgeon whether they’ve collected enough diagnostic material or need another pass.
This real-time feedback loop is especially valuable for thyroid biopsies. In a study of thyroid FNA procedures, the cytopathologist helped decide the best spot within the nodule to sample based on ultrasound features, assessed the specimen’s quality both with the naked eye and under the microscope, and directed additional passes when needed. A smear that looked like pure blood was flagged as inadequate. Material with a dense or gelatinous consistency was generally considered adequate. If the initial sample fell short, the cytopathologist would suggest targeting areas with the most active-looking tissue and avoiding regions that appeared to be filled with fluid or blood.
ROSE also lets the cytopathologist call for the right ancillary tests at the moment of collection. If a sample looks like lymphoma, for instance, they can immediately set material aside for flow cytometry rather than requiring the patient to come back for a second procedure.
Cancer Screening and Molecular Testing
Cervical cancer screening remains a cornerstone of the field. The traditional Pap smear has evolved into liquid-based cytology, a technique that produces cleaner, more standardized slides by suspending collected cells in a preservative solution rather than smearing them directly onto glass. This reduces obscuring factors like blood and mucus, improves cell preservation, and makes slides compatible with automated screening devices. The cytopathologist reviews flagged slides and makes the final call.
Beyond screening, cytopathologists increasingly guide treatment decisions through molecular testing. When a lung cancer is diagnosed from a needle aspirate, for example, the cytopathologist can order genetic analysis to look for specific mutations that determine which targeted therapy will work best. These tests can identify alterations that make a tumor responsive to particular drugs, or measure biomarkers that predict whether immunotherapy is likely to be effective. A single cell sample from a lung nodule can now yield not just a cancer diagnosis but a molecular profile that shapes the entire treatment plan.
Training and Certification
Becoming a cytopathologist requires a long training pipeline. After four years of medical school, the physician completes a residency in anatomic pathology (or combined anatomic and clinical pathology), which takes three to four years. Then comes a 12-month cytopathology fellowship, during which the trainee develops expertise in FNA technique, slide interpretation, and on-site evaluation. Completion of the fellowship qualifies the candidate for a subspecialty board examination administered by the American Board of Pathology.
Certification isn’t a one-time event. The Board requires ongoing participation in continuing certification, which includes components for lifelong learning, professionalism, and demonstrated improvement in health care practice. This keeps cytopathologists current as diagnostic technology evolves.
Salary and Career Outlook
Cytopathologists earn physician-level salaries. The Bureau of Labor Statistics reported that in May 2024, the average annual wage for pathologists in the United States was $266,020. Physician salaries overall had a median equal to or greater than $239,200 per year, placing pathologists comfortably within the upper range of medical compensation. Salaries vary by practice setting, geographic location, and whether the cytopathologist works in an academic medical center, a private laboratory, or a hospital system.